Mr Stan Perron AM talks of his long time support of the Perron Institute, formerly the Western Australian Neuroscience Research Institute (WANRI), including the recent naming of the Institute in his family’s honour to become the Perron Institute for Translational and Neurological Research.
The Perron family have been contributing to the Institute’s research into muscular dystrophy and other neurological conditions for more than 30 years, initially supporting the work of the Institute’s Founder Emeritus Professor Byron Kakulas AO.
This eventually led to the recent success of the US FDA accelerated approval for a novel treatment for Duchenne muscular dystrophy, by Professors Steve Wilton and Sue Fletcher, using “genetic patches” to mask the error in the gene message that causes Duchenne. The Perron Institute’s track record of research translation continues with its exciting future expansion.
Breakthroughs and beyond
Our aim is to extend this novel technology to as many other conditions and applications as possible. In addition to genetic patching, the Institute is engaged in life-changing research on diseases such as stroke, Parkinson’s, motor neurone and multiple sclerosis. Building on our breakthroughs, the Perron Institute is recruiting the world’s best researchers to undertake cutting-edge research on new treatments for these devastating conditions.